CMX-521

N/A

Report date: 2024/04/02 11:38:36
NME

Base Information

Drug NameCMX-521
Drug Alias NameCMX-521CMX521
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Norovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChimerix Inc
China Registration ClassN/A

Develop Information

Active CompaniesChimerix Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Norovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A